SCHEMBL14191876

SCHEMBL14191876

CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)Nc1ncnc2c1ncn2-c1ccc(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.49
▸ KDR P35968 5/20 0.45
▸ BRAF P15056 7/20 0.43
▸ RAF1 P04049 2/20 0.43
▸ NTRK1 P04629 2/20 0.40
▸ NTRK3 Q16288 1/20 0.40
▸ NTRK2 Q16620 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ RET P07949 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ HDAC11 Q96DB2 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ HDAC9 Q9UKV0 1/20 0.39
▸ HDAC5 Q9UQL6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5119657 0.90 BRAF (0.43) EGFRKDRBRAFRAF1NTRK1
SCHEMBL14191880 0.89 KDR (0.47) KDRBRAFRAF1NTRK1NTRK3
SCHEMBL14191877 0.86 KDR (0.47) KDRBRAFRAF1NTRK1NTRK3
SCHEMBL14191810 0.86 KDR (0.47) KDRBRAFRAF1NTRK1NTRK3
SCHEMBL5105965 0.84 KDR (0.46) EGFRKDRBRAFRAF1NTRK1
SCHEMBL5107312 0.83 BRAF (0.49) KDRBRAFRAF1NTRK1NTRK3
SCHEMBL14191813 0.83 KDR (0.50) KDRBRAFRAF1NTRK1NTRK3
Hydrochloric Acid SCHEMBL5107505 0.82 KDR (0.49) KDRBRAFRAF1NTRK1NTRK3
Hydrochloric Acid SCHEMBL5107509 0.82 KDR (0.49) KDRBRAFRAF1NTRK1NTRK3
SCHEMBL5110359 0.82 KDR (0.51) KDRBRAFRAF1NTRK1NTRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080119466-A1 Heteroarylphenylurea Derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-22 — — US disclosed
US-20080119466-A1 Heteroarylphenylurea Derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119466-A1 Heteroarylphenylurea Derivative CHRM1, CBR3, CHRM2 EGFR 2022/4885KDR 2440/4885BRAF 1735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback